课题基金 / 基金详情

Analysis of the CD47-SHPS-1 signaling system in autoimmune disease

Analysis of the CD47-SHPS-1 signaling system in autoimmune disease
自身免疫性疾病中CD47-SHPS-1信号系统的分析
批准号:
18591098
负责人:
KANEKO Yoriaki
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 (SHPS-1), which is originally identified as a substrate for protein tyrosine phosphatases SHP-1 and SHP-2, is a member of immunoglobulin superfamily. SHPS-1 contains ITIM in its intracellular domain and its extra-cellular region interacts with CD47, which is widely expressed on immune cells. The interaction between CD47 and SHPS-1 constitutes a cell-cell communication system (the CD47-SHPS-1 signaling system) that may function in regulation of a variety of biological responses. SHPS-1 is predominantly exposed on macrophages and dendritic cells (DCs), and the CD47-SHPS-1 signaling system is considered to be a negative regulator of immune responses. We investigated the physiological roles of SHPS-1 by the use of SHPS-1 mutant mice, which lack most of the cytoplasmic region of its protein and we revealed some important functions. SHPS-1 negatively regulates the phagocytosis of RBCs by splenic macrophages and it determines both the lifespan of individual RBCs and the number of circulating erythrocytes. SHPS-1 on DCs is essential for both priming of naive T cells and the activation of NKT cells. SHPS-1 positively regulates the development of autoimmune disease and α-GalCer-induced anti-metastatic activities. These results indicate the CD47-SHPS-1 signaling system plays important roles in immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4049/jimmunol.178.10.6164
发表时间: 2007-05-15
期刊: JOURNAL OF IMMUNOLOGY
影响因子: 4.4
作者: [Okajo, Jun, Kaneko, Yoriaki, Nojima, Yoshihisa]
通讯作者: Nojima, Yoshihisa
Enhanced phagocytosis of CD47-deficient red blood cells by spienic macrophages requires SHPS-1
精神巨噬细胞增强 CD47 缺陷红细胞的吞噬作用需要 SHPS-1
DOI: --
发表时间: 2007
期刊: Biochem Biophys Res Commun 343(4)
影响因子: --
作者: [Ishikawa-Sekigami T, Kaneko Y, et. al.]
通讯作者: et. al.
Regulation by SHPS-1 of α-GalCer-induced antimetastatic activity and Th1 and Th2 responses of natural killer T cells.
SHPS-1 对 α-GalCer 诱导的抗转移活性以及自然杀伤 T 细胞的 Th1 和 Th2 反应的调节。
DOI: --
发表时间: 2007
期刊: J. Immunol. 178
影响因子: --
作者: [Okajo, J., et. al.]
通讯作者: et. al.
DOI: 10.1016/j.bbrc.2008.04.124
发表时间: 2008-07-04
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Okuzawa, Chie, Kaneko, Yoriaki, Nojima, Yoshihisa]
通讯作者: Nojima, Yoshihisa
10
    国内基金
    海外基金
    基于铁死亡与CD47固有免疫检查点的共递送纳米药物增强骨肉瘤免疫治疗的研究
    • 批准号:
      2026JJ82540
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      胡欣
    • 依托单位:
    放射治疗诱导DLG1与CD47共表达促进乳腺肿瘤免疫逃逸
    • 批准号:
      2026JJ60027
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      罗舒凤
    • 依托单位:
    血小板反应蛋白-1/CD47信号调控糖尿病视网膜病变炎症反应机制研究
    • 批准号:
      2026JJ80372
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王会艳
    • 依托单位:
    hUC-MSCs来源的THBS2通过CD47/PPAR-α/GPX4通路抑制腺泡细胞铁死亡治疗急性胰腺炎的机制研究
    • 批准号:
      2026JJ30203
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      黄耿文
    • 依托单位: